LUNG CANCER (DIAGNOSIS)
Clinical trials for LUNG CANCER (DIAGNOSIS) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (DIAGNOSIS) trials appear
Sign up with your email to follow new studies for LUNG CANCER (DIAGNOSIS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New surgical stapler shows promise in lung cancer operations
Disease control CompletedThis study tested a new surgical stapler (easyEndo™ Lite) in 30 people undergoing lung cancer surgery. The goal was to see if the device safely cuts and seals lung tissue. Researchers checked for successful sealing, surgery time, blood loss, and complications. The study is comple…
Matched conditions: LUNG CANCER (DIAGNOSIS)
Phase: NA • Sponsor: Ezisurg Medical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Phone app could boost lung recovery after surgery
Symptom relief CompletedThis pilot study tested whether a smartphone-based program could help high-risk patients recover their breathing after lung surgery. Fifty-eight adults who had lung resection and were either older or had reduced lung function were split into two groups: one used a smartphone app …
Matched conditions: LUNG CANCER (DIAGNOSIS)
Phase: NA • Sponsor: Pusan National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Wearable devices track lung cancer recovery after surgery
Knowledge-focused CompletedThis study watches 300 lung cancer patients to see how they recover after one of two surgeries: removing a small part of the lung (sublobar resection) or a larger section (lobectomy). Participants wear a digital device and answer questions about pain, cough, and tiredness. The go…
Matched conditions: LUNG CANCER (DIAGNOSIS)
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes pill may cut lung cancer risk in COPD patients, study suggests
Knowledge-focused CompletedThis study looked at medical records of over 21,000 adults with type 2 diabetes and COPD to see if a diabetes drug called SGLT2 inhibitor lowers the chance of getting lung cancer compared to an older drug, sulfonylurea. Researchers did not give anyone new medicine; they just anal…
Matched conditions: LUNG CANCER (DIAGNOSIS)
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC